Gene · 64332
NFKBIZ: NFKB inhibitor zeta
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. NFKBIZ: NFKB inhibitor zeta. Genes, record 64332. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/64332
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9BYH8 | NF-kappa-B inhibitor zeta | 718 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents59
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 56013 | Q9BYH8 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 5620 | Q9BYH8 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 5262 | Q9BYH8 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 4984 | Q9BYH8 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 15380 | Q9BYH8 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 5262 | Q9BYH8 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 5620 | Q9BYH8 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 15380 | Q9BYH8 | Espacenet |
| KR 1020250017231 A | 2025-02-04 | 4984 | Q9BYH8 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 15380 | Q9BYH8 | Espacenet |
1 to 10 of 59
See all 59 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,216
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | NFKBIZ papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 8 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 8 | 2025 |
| P30CA060553 | The Robert H. Lurie Comprehensive Cancer Center | 5 | 2025 |
| R37DE022550 | Host and Fungal Regulation of Type 17 Immunity to Oral Candidiasis | 5 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 5 | 2025 |
| P30CA034196 | Cancer Center Support (CORE) Grant | 3 | 2025 |
| P30CA072720 | Cancer Center Support Grant | 3 | 2025 |
| U01DK062422 | Mount Sinai NYC Genetics Research Center: Multi-omic integration across data-types, cell niches and populations | 3 | 2025 |
| U01DK062432 | Montreal-Boston Collaborative GRC | 3 | 2025 |
| P01CA013106 | Targeting Transcription and Splicing in Cancer | 2 | 2025 |
1 to 10 of 1,216Source NIH's project files
See all 1,216 nih grantsPapers1,512
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pathology-Guided Transcriptomic Profiling of Prostate Cancer Identifies Grade-Associated Proliferative and Immune Signatures in a MENA Cohort. | Cancers (Basel) | 2026 | 42794866 | PubTator, text mining | PubMed |
| The regulation of COX-2, ABCA1, and ABCG1 by the lncRNA PACERR links the inflammatory response and cholesterol homeostasis. | Cell Rep | 2026 | 42696452 | PubTator, text mining | PubMed |
| IL-1β-Induced Inflammatory Transcriptome and TGF-β1 Attenuation of Chemokine Expression in ACL Remnant Fibroblasts. | Am J Sports Med | 2026 | 42606104 | PubTator, text mining | PubMed |
| Molecular Pathogenesis and Therapeutic Response of Diffuse Large B Cell Lymphoma Genetic Subtypes. | Annu Rev Cancer Biol | 2026 | 42487683 | PubTator, text mining | PubMed |
| NOX1 drives inflammatory bowel disease through oxidant-dependent stabilization of IκBζ. | Free Radic Biol Med | 2026 | 42480953 | PubTator, text mining | PubMed |
| Common genetic variants of the cardiac sodium channel alter patient response to class 1b antiarrhythmics. | J Precis Med (Amst) | 2026 | 42422555 | PubTator, text mining | PubMed |
| [Early transcriptomic features of neutrophils and monocytes activated by the outer membrane protein MSP2 of anaplasma phagocytophilum]. | Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi | 2026 | 42350344 | PubTator, text mining | PubMed |
| Genome-wide association and Mendelian randomization analyses link Helicobacter pylori infection to Human Leukocyte Antigen polymorphisms and autoimmune diseases. | medRxiv | 2026 | 42051570 | PubTator, text mining | PubMed |
| Functional segregation of HIF-1α and AhR controls NK cell responsiveness under hypoxia. | iScience | 2026 | 42006290 | PubTator, text mining | PubMed |
| Ionic-liquid-facilitated transdermal absorption of lidocaine hydrochloride. | PLoS One | 2026 | 41931479 | PubTator, text mining | PubMed |
1 to 10 of 1,512
See all 1,512 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/64332
GET https://conductscience.org/api/genes/v1/64332/patents?page=2